Form 4: Medtronic Director Powell Reports Share Transactions

Sentiment:

Statement of Changes in Beneficial Ownership


Medtronic plc director Kendall J. Powell reported transactions involving ordinary shares, including an award of restricted stock units and shares withheld for tax payments.

Summary

  • Kendall J. Powell, a Director at Medtronic plc, reported transactions on April 27 and April 28, 2026.
  • On April 27, 2026, 2,111 ordinary shares were acquired as an award of restricted stock units (RSUs) that vest one year after the award date.
  • Following this award, Mr. Powell beneficially owns 51,587 ordinary shares.
  • Additionally, 854 shares were acquired through dividend reinvestment since the last report.
  • On April 28, 2026, 207 shares were disposed of, with the transaction code indicating shares withheld for tax payments upon the vesting of previously reported RSUs.
  • The disposal price was $81.9 per share.
  • After this transaction, Mr. Powell beneficially owns 51,380 ordinary shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports routine insider transactions related to equity awards and tax payments, with no significant positive or negative implications for the company's financial health or strategic direction.

Positives

  • Award of restricted stock units (2,111 shares) indicates continued equity-based compensation and potential long-term incentive for the director.
  • Acquisition of 854 shares through dividend reinvestment shows a growing stake in the company through passive income.
  • The company is managing tax obligations efficiently by withholding shares upon RSU vesting.

Negatives

  • Disposal of 207 shares to cover tax obligations, while standard, represents a reduction in direct beneficial ownership.

Future Outlook

The filing does not contain forward-looking statements or guidance. The RSUs awarded vest on the one-year anniversary of the award date, indicating a future vesting event.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The transactions reported by Medtronic plc director Kendall J. Powell are typical for executive compensation and tax management related to equity awards within the medical device industry.

Stakeholder Impact

  • Shareholders: The transactions are routine and do not suggest a change in the director's overall commitment to the company. The dividend reinvestment indicates a growing personal investment.
  • Employees: The RSU award and tax withholding are standard compensation practices that do not directly impact other employees.
  • Creditors: No direct impact on creditors is indicated by these transactions.

Next Steps

  • Restricted stock units awarded on 04/27/2026 are scheduled to vest on the one-year anniversary of the award date.

Key Dates

DateDescription
04/27/2026Earliest transaction date reported; award of restricted stock units.
04/28/2026Transaction date for shares withheld for tax payments.
04/29/2026Signature date for the filing.

Keywords

Medtronic plc, MDT, Form 4, Insider Trading, Stock Options, Restricted Stock Units, Director Transactions, Beneficial Ownership, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.